<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ruleSet xmlns="http://semanticbits.com/rules/brxml"><id>d5dc011a-8cfe-4df4-bd4e-ae283489212b</id><name>gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.sae_reporting_rules</name><description>SAE Reporting Rules</description><subject>Sponsor defined rules for a study||Cancer Therapy Evaluation Program||Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</subject><coverage>Enabled</coverage><import>gov.nih.nci.cabig.caaers.domain.*</import><rule id="22fdb4c7-bf85-4e4b-9724-a4aea5b7c37d"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>Non-CTEP IND 7 Calendar Day Report</action><readableAction>Non-CTEP IND 7 Calendar Day Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.sae_reporting_rules" name="Rule-1" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line></readableRule></rule><rule id="21f95eaf-bef5-420c-a414-4c766e5f5180"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>Non-CTEP IND 3 Day Expedited Report</action><action>Non-CTEP IND 24 Hour SAE Notification</action><readableAction>Non-CTEP IND 3 Day Expedited Report</readableAction><readableAction>Non-CTEP IND 24 Hour SAE Notification</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.sae_reporting_rules" name="Rule-2" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="0bf1ce0e-9679-4cd6-b788-d61cd0c67233"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Outcome Identifier " grammer-postfix="" field-name="outcomeIdentifier" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>4</value><value>5</value><readable-value>congenital anomaly/birth defect,disability or permanent damage,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.OutcomeType','code','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>Non-CTEP IND 7 Calendar Day Report</action><readableAction>Non-CTEP IND 7 Calendar Day Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.sae_reporting_rules" name="Rule-3" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Outcome Identifier is  'congenital anomaly/birth defect'  or 'disability or permanent damage' </line></readableRule></rule><rule id="a5842359-38b1-4d79-a09b-75f4ddcacda6"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>5</value><readable-value>Grade 5</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>Non-CTEP IND 7 Calendar Day Report</action><readableAction>Non-CTEP IND 7 Calendar Day Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.sae_reporting_rules" name="Rule-4" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 5' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is  'Unlikely'  or 'Unrelated' </line></readableRule></rule></ruleSet>

